GSK Investigational Site

Bad Saarow, Brandenburg 15526

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer's Disease, Sarcoma, Soft Tissue

Studies at this site

• Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers — Stopped early
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease — Completed
• Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy — Completed